Tobias Dallenga

3.4k total citations
16 papers, 654 citations indexed

About

Tobias Dallenga is a scholar working on Infectious Diseases, Epidemiology and Immunology. According to data from OpenAlex, Tobias Dallenga has authored 16 papers receiving a total of 654 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Infectious Diseases, 7 papers in Epidemiology and 7 papers in Immunology. Recurrent topics in Tobias Dallenga's work include Tuberculosis Research and Epidemiology (9 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (6 papers) and Pneumocystis jirovecii pneumonia detection and treatment (4 papers). Tobias Dallenga is often cited by papers focused on Tuberculosis Research and Epidemiology (9 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (6 papers) and Pneumocystis jirovecii pneumonia detection and treatment (4 papers). Tobias Dallenga collaborates with scholars based in Germany, United Kingdom and United States. Tobias Dallenga's co-authors include Ulrich E. Schaible, Christine Stadelmann, Wolfgang Brück, Urška Repnik, Gareth Griffiths, Rudolph Reimer, Björn Corleis, Fatima König, Tomasz Dziedzic and Sven Müller and has published in prestigious journals such as NeuroImage, Scientific Reports and Free Radical Biology and Medicine.

In The Last Decade

Tobias Dallenga

16 papers receiving 646 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tobias Dallenga Germany 10 226 188 177 157 123 16 654
Başak Kayhan Türkiye 14 44 0.2× 190 1.0× 147 0.8× 129 0.8× 20 0.2× 28 659
Markus C. Kowarik Germany 15 70 0.3× 357 1.9× 483 2.7× 62 0.4× 60 0.5× 48 977
Yuri Nakamura Japan 13 90 0.4× 115 0.6× 226 1.3× 115 0.7× 16 0.1× 30 521
Peter Wipfler Austria 17 142 0.6× 168 0.9× 362 2.0× 65 0.4× 14 0.1× 56 658
Florence Pache Germany 20 53 0.2× 337 1.8× 596 3.4× 132 0.8× 98 0.8× 38 1.2k
E. Kinnunen Finland 17 150 0.7× 83 0.4× 266 1.5× 111 0.7× 25 0.2× 37 928
Hiroyuki Torisu Japan 17 150 0.7× 116 0.6× 36 0.2× 113 0.7× 20 0.2× 57 804
S D Miller United States 10 50 0.2× 527 2.8× 171 1.0× 99 0.6× 70 0.6× 15 802
Laurie Zoecklein United States 14 42 0.2× 186 1.0× 178 1.0× 45 0.3× 15 0.1× 24 559
Andrea Colliva Italy 12 234 1.0× 102 0.5× 21 0.1× 39 0.2× 68 0.6× 20 805

Countries citing papers authored by Tobias Dallenga

Since Specialization
Citations

This map shows the geographic impact of Tobias Dallenga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tobias Dallenga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tobias Dallenga more than expected).

Fields of papers citing papers by Tobias Dallenga

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tobias Dallenga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tobias Dallenga. The network helps show where Tobias Dallenga may publish in the future.

Co-authorship network of co-authors of Tobias Dallenga

This figure shows the co-authorship network connecting the top 25 collaborators of Tobias Dallenga. A scholar is included among the top collaborators of Tobias Dallenga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tobias Dallenga. Tobias Dallenga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Braunstein, Ilana, Hozumi Motohashi, Tobias Dallenga, Ulrich E. Schaible, & Moran Benhar. (2025). Redox signaling in innate immunity and inflammation: focus on macrophages and neutrophils. Free Radical Biology and Medicine. 237. 427–454. 8 indexed citations
2.
Theobald, Sebastian J., Christian Utpatel, Manuel Koch, et al.. (2024). Discovery of dual-active ethionamide boosters inhibiting the Mycobacterium tuberculosis ESX-1 secretion system. Cell chemical biology. 31(4). 699–711.e6. 6 indexed citations
3.
Barilar, Ivan, Sönke Andres, Tobias Dallenga, et al.. (2024). Molecular determinants of multidrug-resistant tuberculosis in Sierra Leone. Microbiology Spectrum. 12(3). e0240523–e0240523. 1 indexed citations
4.
Schaible, Ulrich E., et al.. (2022). Evaluation of Myeloperoxidase as Target for Host-Directed Therapy in Tuberculosis In Vivo. International Journal of Molecular Sciences. 23(5). 2554–2554. 4 indexed citations
5.
Dallenga, Tobias, Christian Utpatel, Jochen Behrends, et al.. (2021). Survival of hypoxia-induced dormancy is not a common feature of all strains of the Mycobacterium tuberculosis complex. Scientific Reports. 11(1). 2628–2628. 11 indexed citations
6.
Dallenga, Tobias, Raylene A. Reimer, Kerstin Schepanski, et al.. (2020). Enhanced tenacity of mycobacterial aerosols from necrotic neutrophils. Scientific Reports. 10(1). 9159–9159. 9 indexed citations
7.
Schaible, Ulrich E., et al.. (2017). Strategies to Improve Vaccine Efficacy against Tuberculosis by Targeting Innate Immunity. Frontiers in Immunology. 8. 1755–1755. 25 indexed citations
8.
Dallenga, Tobias, et al.. (2017). Targeting neutrophils for host-directed therapy to treat tuberculosis. International Journal of Medical Microbiology. 308(1). 142–147. 33 indexed citations
9.
Dallenga, Tobias, Urška Repnik, Björn Corleis, et al.. (2017). M. tuberculosis-Induced Necrosis of Infected Neutrophils Promotes Bacterial Growth Following Phagocytosis by Macrophages. Cell Host & Microbe. 22(4). 519–530.e3. 166 indexed citations
10.
Singh, Shailender, Tobias Dallenga, Anne Winkler, et al.. (2017). Relationship of acute axonal damage, Wallerian degeneration, and clinical disability in multiple sclerosis. Journal of Neuroinflammation. 14(1). 57–57. 80 indexed citations
11.
Herzmann, Christian, Tobias Dallenga, & Ulrich Kalinke. (2017). Pulmonale Immunität bei Tuberkulose. Pneumologie. 72(7). 493–502. 2 indexed citations
12.
Dallenga, Tobias & Ulrich E. Schaible. (2016). Neutrophils in tuberculosis – first line of defence or booster of disease and targets for host directed therapy?. Pathogens and Disease. 74(3). ftw012–ftw012. 68 indexed citations
13.
Dallenga, Tobias, Björn Corleis, & Ulrich E. Schaible. (2015). Infection of Human Neutrophils to Study Virulence Properties of Mycobacterium tuberculosis. Methods in molecular biology. 1285. 343–355. 2 indexed citations
14.
Dallenga, Tobias, et al.. (2014). Immunomagnetic Isolation of Pathogen‐Containing Phagosomes and Apoptotic Blebs from Primary Phagocytes. Current Protocols in Immunology. 105(1). 14.36.1–14.36.26. 14 indexed citations
15.
Boretius, Susann, Tobias Dallenga, Claudia Wrzos, et al.. (2011). Assessment of lesion pathology in a new animal model of MS by multiparametric MRI and DTI. NeuroImage. 59(3). 2678–2688. 103 indexed citations
16.
Dziedzic, Tomasz, Imke Metz, Tobias Dallenga, et al.. (2010). Wallerian Degeneration: A Major Component of Early Axonal Pathology in Multiple Sclerosis. Brain Pathology. 20(5). 976–985. 122 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026